---
schema_version: "secwatch.filing_event.v1"
accession: "0001903596-24-000596"
form_type: "8-K"
ticker: "LUDG"
cik: "0001960262"
company_name: "LUDWIG ENTERPRISES, INC."
filed_at: "2024-09-24T23:59:59+00:00"
generated_at: "2026-05-31T02:11:56.237634+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Ludwig Enterprises announces AI-powered cheek swab cancer screening technology Revealia

## Summary
- Revealia uses AI-driven analysis of mRNA genetic signals from a mail-order non-invasive cheek swab to detect early signs of cancer.
- Proprietary Revealia Inflammatory Index (RII) quantifies cancer risk using machine learning that continuously improves with new patient data.
- Analysis based on mRNA samples from over 40 multipurpose medical clinics across the United States.
- No specific launch date, financial projections, or regulatory status disclosed in the announcement.

## SEC filing metadata
- accession: 0001903596-24-000596
- form_type: 8-K
- ticker: LUDG
- cik: 0001960262
- company_name: LUDWIG ENTERPRISES, INC.
- filed_at: 2024-09-24T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1960262/000190359624000596/0001903596-24-000596-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1960262/000190359624000596/ludg_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001903596-24-000596
- JSON: https://secwatch.observer/filing/0001903596-24-000596.json
- Plain text: https://secwatch.observer/filing/0001903596-24-000596.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.